Semax
Semax. Russian nootropic ACTH analog for cognitive enhancement.
How it works. Increases BDNF expression and modulates neurotrophins.
What the research supports. 1 graded claims. Strongest: Improves cognition post-stroke (moderate).
How much to take. Typical dose: 250–600 mcg intranasal.
Side effects and interactions. 1 medication interaction listed. No serious side effects listed at normal doses.
Stacking. Pairs well with Omega-3 (EPA/DHA), Alpha-GPC or CDP-choline.
Common forms. Available as Subcutaneous injection, Oral or sublingual lozenge, Nasal spray, Compounded topical.
Key studies. 8 studies cited. The strongest are listed with links to PubMed.
Community. Experiences from people who have tried Semax. Anecdotes are not medical advice.
Semax. Russian nootropic ACTH analog for cognitive enhancement.
What it is
Russian nootropic ACTH analog for cognitive enhancement.
Food sources
Goals
How it works
Increases BDNF expression and modulates neurotrophins.
Pathways
- Increases BDNF expression
- modulates neurotrophins
Effects
- +cognition post-stroke supports
What the research supports
Strong: consistent results across large trials or meta-analyses. Moderate: several trials, mostly positive. Limited: small or mixed studies. Preclinical: animal or cell research only.
Side effects & interactions
Common side effects
- Mild nasal irritation
Medication interactions
Always disclose Semax use to your prescriber — additive, antagonistic, or pharmacokinetic interactions are possible.
Check any supplement–medication combination with your pharmacist before starting.
Combines with
Pairs well
- Omega-3 (EPA/DHA)Membrane fluidity and neuronal signaling support.
- Alpha-GPC or CDP-cholineProvides choline substrate for acetylcholine synthesis.
Common forms
- Subcutaneous injection
- Oral or sublingual lozenge
- Nasal spray
- Compounded topical
Key studies
8 studies cited in total.
Opens current human and preclinical literature matching Semax and "Improves cognition post-stroke". Filter by RCT, meta-analysis, or year on the results page.
Opens current human and preclinical literature matching Semax and "randomized controlled trial". Filter by RCT, meta-analysis, or year on the results page.
Opens current human and preclinical literature matching Semax and "meta-analysis". Filter by RCT, meta-analysis, or year on the results page.
Discussion
Loading discussion…